VIR BIOTECHNOLOGY INC (VIR) Stock News

NASDAQ:VIR - Nasdaq - US92764N1028 - Common Stock - Currency: USD

5.41 -0.08 (-1.46%)

After market: 5.41 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

VIR Latest News, Press Relases and Analysis

All

Press Releases

9 days ago - By: Benzinga - Mentions: GALT RARE PRPO INKT ...

12 Health Care Stocks Moving In Friday's After-Market Session

10 days ago - By: Benzinga

Where Vir Biotechnology Stands With Analysts

2 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

2 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology to Participate in TD Cowen 6th Annual Oncology Innovation Summit

2 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference

2 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study

2 months ago - By: Zacks Investment Research - Mentions: AGEN

Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Lags Revenue Estimates

2 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results

3 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology to Provide Corporate Update and Report First Quarter 2025 Financial Results on May 7, 2025

3 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Liver (EASL) Congress 2025

3 months ago - By: Yahoo Finance - Mentions: IOVA DAWN ARVN NUVB ...

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: RLAY KIND GOSS DAWN ...

Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: GOSS PRLD DAWN NUVB ...

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple

6 months ago - By: Investor's Business Daily

Vir Biotechnology Catapults 62% On Promising Results In Cancer Treatment

3 months ago - By: Yahoo Finance - Mentions: NUVB RLAY TSLA DAWN ...

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: ARVN DAWN WMT NUVB ...

Arvinas, Inc. (ARVN): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance

Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple

4 months ago - By: Brii Biosciences Limited

Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results

4 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta

5 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

5 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference

5 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

6 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC

7 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

7 months ago - By: Vir Biotechnology, Inc.

Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta